Visit KQAK 105.7
Visit The Peak 104.1
Visit 95.7 The Ranch
Visit 92.5 The Ticket
Visit KBNW 104.5AM AND 1340AM
Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about psychedelic compound MEAI

Recent news which mentions psychedelic compound MEAI

EXCLUSIVE: Clearmind Medicine Secures Approval To Launch Clinical Trial For Alcohol Addiction Treatment
Tickers CMND
Tags alcohol use disorder Market News psychedelic compound MEAI
From Benzinga
Next-Gen Israeli Psychedelics Company Gears Up For Trial Targeting Alcohol Addiction
Tickers CMND
Tags Psychedelic/Assisted Therapies Benzinga Markets
From Benzinga
Psyched Clinical Trials: Australian Univ. Pursues MDMA, MEAI Compound About To Set Off
Tickers CMND
Tags PharmAla Biotech Market News Contracts
From Benzinga
A Drug That Mimics Alcohol Buzz Is Bound For Human Trials: Here's What's Next
Tickers CMND
Tags alcohol use disorder Market News Psychedelic/Assisted Therapies
From Benzinga
EXCLUSIVE: Next-Generation Psychedelics, MEAI - The Road Ahead
Tickers CMND
Tags CMND Next/Generation Psychedelics Penny Stocks
From Benzinga
EXCLUSIVE: Next-Generation Psychedelics, MEAI - What And When
Tickers CMND
Tags alcohol use disorder Market News psychedelic compound MEAI
From Benzinga
EXCLUSIVE: Next-Generation Psychedelics, MEAI - How And Why, An Israeli Scientist Explains
Tickers CMND
Tags Market News Benzinga alcohol abuse disorder
From Benzinga
Next-Generation Psychedelics: The Case Of MEAI And Its Potential To Treat Addiction
Tickers CMND
Tags Market News Psychedelic/Assisted Therapies Addictions
From Benzinga
Psychedelic-Based Cocaine Addiction Treatment Study Showing Positive Results. This Is What We Know
Tickers CMNDF SPRC
Tags psychedelic compound MEAI SciSparc Penny Stocks
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.